📊 CLIR Key Takeaways
Investment Thesis
ClearSign Technologies is a pre-revenue or early-stage commercialization company burning significant cash with minimal revenue generation ($1.6M) and negative operating cash flow of -$3.5M. Despite holding substantial cash reserves of $10.5M relative to assets, the company is unprofitable with severe operating losses (-$5.8M) and demonstrates no clear path to profitability in the near term.
CLIR Strengths
- Strong liquidity position with $10.5M cash providing runway for operations
- Zero long-term debt eliminates financial obligations and solvency risk
- Solid current ratio of 3.28x indicates short-term financial flexibility
- Positive gross margin of 39.6% suggests product-level economics are viable when revenue is achieved
CLIR Risks
- Severe cash burn rate of -$3.5M annually will deplete reserves within 3 years if not reversed
- Revenue of only $1.6M against operating expenses indicates business model is far from viability
- Negative operating margin of -374% and net margin of -331.7% demonstrate inability to control costs relative to revenue
- Operating losses of -$5.8M dwarf revenue, suggesting product commercialization is failing to gain traction
- Free cash flow of -$3.5M and ROE of -57.1% indicate value destruction and poor capital deployment
Key Metrics to Watch
- Quarterly revenue growth trajectory and path to positive operating cash flow
- Monthly cash burn rate and runway extension timeline
- Gross margin sustainability and operating expense reduction initiatives
- Progress on product commercialization and customer acquisition metrics
CLIR Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 3.28x current ratio provides a solid financial cushion.
CLIR Profitability Ratios
CLIR vs Industrial Sector
How ClearSign Technologies Corp compares to Industrial sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
CLIR Balance Sheet & Liquidity
CLIR 5-Year Financial Trend
5-Year Trend Summary: ClearSign Technologies Corp's revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-0.04 indicates the company is currently unprofitable.
CLIR Growth Metrics (YoY)
CLIR Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $1.0M | -$1.2M | N/A |
| Q2 2025 | $45.0K | -$1.7M | $-0.03 |
| Q1 2025 | $401.0K | -$1.1M | $-0.03 |
| Q3 2024 | $85.0K | -$1.2M | N/A |
| Q2 2024 | $45.0K | -$1.5M | $-0.04 |
| Q1 2024 | $894.0K | -$1.1M | $-0.03 |
| Q3 2023 | $85.0K | -$1.3M | $-0.03 |
| Q2 2023 | $150.0K | -$1.5M | $-0.04 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
CLIR Capital Allocation
CLIR SEC Filings
Access official SEC EDGAR filings for ClearSign Technologies Corp (CIK: 0001434524)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CLIR
What is the AI rating for CLIR?
ClearSign Technologies Corp (CLIR) has an AI rating of STRONG SELL with 92% confidence, based on fundamental analysis of SEC EDGAR filings.
What are CLIR's key strengths?
Strong liquidity position with $10.5M cash providing runway for operations. Zero long-term debt eliminates financial obligations and solvency risk.
What are the risks of investing in CLIR?
Severe cash burn rate of -$3.5M annually will deplete reserves within 3 years if not reversed. Revenue of only $1.6M against operating expenses indicates business model is far from viability.
What is CLIR's revenue and growth?
ClearSign Technologies Corp reported revenue of $1.6M.
Does CLIR pay dividends?
ClearSign Technologies Corp does not currently pay dividends.
Where can I find CLIR SEC filings?
Official SEC filings for ClearSign Technologies Corp (CIK: 0001434524) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CLIR's EPS?
ClearSign Technologies Corp has a diluted EPS of $-0.07.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.